Pentair plc (PNR)
Senator Markwayne Mullin recently filed a purchase of shares in Pentair, a water treatment company highlighted by Quiver Quantitative. The trade is notable because it's the first time in over a year that a member of Congress has been reported buying PNR, which may draw renewed attention from retail and institutional investors following the disclosure.
Pentair specializes in water and fluid flow solutions, including pumps, filtration systems, and related aftermarket services for residential, commercial, and industrial customers. With growing focus on infrastructure and water management, this newly reported congressional purchase could prompt investors to re-evaluate Pentair's positioning in water-treatment markets and its potential exposure to infrastructure-driven demand. PNR may see increased scrutiny in the short term as traders and analysts digest the filing.
$PNR Insider Trading Activity
$PNR insiders have traded $PNR stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $PNR stock by insiders over the last 6 months:
- ROBERT P FISHMAN (EVP & Chief Financial Officer) has made 0 purchases and 8 sales selling 7,786 shares for an estimated $820,765.
- T MICHAEL GLENN sold 6,558 shares for an estimated $684,196
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PNR Hedge Fund Activity
We have seen 391 institutional investors add shares of $PNR stock to their portfolio, and 359 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 5,525,601 shares (+262.8%) to their portfolio in Q3 2025, for an estimated $612,015,566
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,577,036 shares (+65.3%) to their portfolio in Q3 2025, for an estimated $285,432,507
- NORDEA INVESTMENT MANAGEMENT AB added 1,800,669 shares (+173.6%) to their portfolio in Q3 2025, for an estimated $199,442,098
- BLACKROCK, INC. removed 1,741,567 shares (-10.2%) from their portfolio in Q3 2025, for an estimated $192,895,960
- AMERIPRISE FINANCIAL INC added 1,670,944 shares (+106.7%) to their portfolio in Q3 2025, for an estimated $185,073,757
- ALLIANCEBERNSTEIN L.P. removed 1,217,896 shares (-46.6%) from their portfolio in Q3 2025, for an estimated $134,894,160
- VALEO FINANCIAL ADVISORS, LLC removed 1,000,910 shares (-99.8%) from their portfolio in Q3 2025, for an estimated $110,860,791
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PNR Congressional Stock Trading
Members of Congress have traded $PNR stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PNR stock by members of Congress over the last 6 months:
- SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 11/10.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$PNR Analyst Ratings
Wall Street analysts have issued reports on $PNR in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 10/22/2025
- RBC Capital issued a "Outperform" rating on 10/22/2025
- JP Morgan issued a "Overweight" rating on 10/15/2025
- B of A Securities issued a "Underperform" rating on 07/29/2025
- Baird issued a "Outperform" rating on 07/23/2025
- Mizuho issued a "Outperform" rating on 07/23/2025
- Oppenheimer issued a "Outperform" rating on 07/23/2025
To track analyst ratings and price targets for $PNR, check out Quiver Quantitative's $PNR forecast page.
$PNR Price Targets
Multiple analysts have issued price targets for $PNR recently. We have seen 11 analysts offer price targets for $PNR in the last 6 months, with a median target of $124.0.
Here are some recent targets:
- Julian Mitchell from Barclays set a target price of $115.0 on 12/04/2025
- Bryan Blair from Oppenheimer set a target price of $128.0 on 11/20/2025
- Damian Karas from UBS set a target price of $124.0 on 10/22/2025
- Deane Dray from RBC Capital set a target price of $124.0 on 10/22/2025
- Stephen Tusa from JP Morgan set a target price of $126.0 on 10/15/2025
- Andrew Kaplowitz from Citigroup set a target price of $133.0 on 10/09/2025
- Andrew Obin from B of A Securities set a target price of $100.0 on 07/29/2025
